MLR Review: Why Your Team Waits Weeks — And How AI Changes That

It's Monday morning. Your team has spent four weeks on a new campaign — copy, visuals, claims, everything carefully crafted. You submit the materials for MLR review. And then: waiting. Two, three, sometimes six weeks. Feedback comes back — unclear, scattered across email threads, with comments on a version that's long outdated. You correct, resubmit, wait again. Three rounds later, you've spent more time on the approval process than on the actual campaign.

This isn't an edge case. This is everyday life in healthcare marketing.

The MLR process — Medical, Legal, Regulatory review — is one of the most important safety functions in the life sciences industry. But in its current form, it slows teams down, costs millions, and prevents good content from ever reaching the right audience. The good news: AI compliance tools can change this — structurally, measurably, now.

Why the MLR process structurally fails

It's broken because Medical, Legal, and Regulatory teams must handle a content volume that has multiplied in recent years — with the same resources. The structures were never designed for this volume — teams simply can't keep up.

Three factors drive the problem:

1. The versioning problem

Medical reviews version 3. Legal commented on version 2. Regulatory is checking version 1. Everyone is doing their job — but in the end, the review fails not because of content errors, but because a single, authoritative source file never existed. The consequences are predictable: teams lose track of approved versions, reviewers comment on already-revised material, and approvals reference documents that don't match the final state.¹

2. The volume problem

Omnichannel marketing means more content, for more channels, in more markets, with local compliance requirements. Geographic variations in compliance requirements and the exponential growth of digital content volumes have significantly increased the workload — without teams or processes scaling accordingly. The result: higher error rates and burnout in MLR teams.¹

3. The revision problem

Pharma marketing teams typically plan for two to three revision rounds. More than half of all pharma marketers need new materials every two months — and every additional revision round costs time, budget, and engagement windows that can't be recovered.²

The result: marketing teams wait up to 40 days for approval. Competitors who get through on the first attempt reach HCPs earlier, more frequently, and more personally. The gap is nearly impossible to close.

What's at stake — concretely

The MLR bottleneck isn't an operational nuisance. It has direct business consequences.

• Competitive disadvantage: Those who reach HCPs later than competitors lose engagement windows that can't be recovered. HCP engagement with pharma field forces and online channels is already at just 53% according to a Veeva study (2024) — and 62% of reachable HCPs interact with only three or fewer companies.²
• Direct process costs: The five largest US settlements for improper drug advertising alone total over $10 billion — from GlaxoSmithKline ($3B) to Eli Lilly ($1.4B). Direct evidence of what poor compliance quality can cost.³
• Team burnout: Rising content volumes, geographic compliance variations, and endless revision loops lead to real exhaustion in MLR teams.¹

In short: a slow MLR process isn't just a process problem. It's a revenue problem.

How AI compliance tools transform the MLR review

AI doesn't solve the MLR problem by replacing the reviewer. It solves it by shifting the problem to where it can be addressed: before submission.

Pre-screening instead of post-correction

Modern AI compliance platforms like Caidera automatically check content before it even enters the formal review process. The system detects:

• Missing references and unsubstantiated claims
• Language that violates HWG, EMA, or FDA guidelines
• Inconsistencies between text and approved claim libraries
• Inappropriate images or regulatory problematic language

The result: content that reaches the MLR team has already passed an automated compliance check. Reviewers can focus on genuinely complex questions — not on errors an algorithm detects in seconds.

A controlled single source of truth

AI solves the versioning problem through structured workflows with a single, traceable document history. All stakeholders — Medical, Legal, Regulatory — work on the same versioned file. Every change is logged, every approval is audit-proof. This eliminates the most common source of errors in the MLR process.

Measurable results

The numbers speak for themselves. Multiple independent industry analyses consistently find that companies with optimized, AI-powered MLR workflows achieve:

• 57% reduction in review cycle time⁴
• 55% less time spent in review meetings⁴

And according to McKinsey analysis, AI agents in compliance processes could mean 4–8% more revenue and 5–9% lower costs over the next five years.²

What this concretely means for your team

The shift AI enables in the MLR process isn't just a speed gain. It changes what your team spends its time on.

Less time on:

• Version tracking via email
• Manual reference checks
• Revision loops caused by avoidable errors
• Waiting for feedback on wrong document versions

More time for:

• Strategy and creative campaign development
• Personalized HCP communication
• Faster time-to-market for new products
• Evidence-based content decisions

AI doesn't replace reviewers. It frees them for the work that actually requires expertise.

Why now is the right time

38% of the MLR process is expected to be AI-driven by 2028, according to a focus group of executives from ten biopharma companies.² Those who wait now won't just be slower than the competition — they'll be stuck in a structure that becomes increasingly difficult to escape.

The technology is available today. The processes to integrate it are proven. And the companies that adopt early are building an advantage that translates directly into HCP engagement.

The MLR review is broken. But it doesn't have to stay that way.

Conclusion: Compliance as competitive advantage

A faster MLR process isn't an operational nice-to-have. It's a strategic advantage — for time-to-market, for HCP engagement, for the quality of content that ultimately gets published.

AI compliance tools like Caidera are built to solve exactly this problem: pre-screening before submission, structured workflows with a single source of truth, automated checks against regulatory guidelines — and measurable results from day one.